Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16056| Title: | Fosfomycin for treatment of prostatitis: new tricks for old dogs | Austin Authors: | Grayson, ML;Macesic, N;Trevillyan, J ;Ellis, AG;Zeglinski, PT;Hewitt, NH;Gardiner, BJ;Frauman, AG | Affiliation: | Infectious Diseases Department of Infectious Diseases, Alfred Health. Department of Medicine, University of Melbourne. Clinical Pharmacology and Therapeutics |
Issue Date: | 1-Oct-2015 | Date: | 2015-06-10 | Publication information: | Clinical Infectious Diseases 2015; 61(7): 1141-1143 | Abstract: | Treatment options for prostatitis caused by multidrug-resistant gram-negative bacilli are limited. We report two cases cured with oral fosfomycin and provide a pharmacokinetic analysis of fosfomycin predose concentrations during treatment. | Description: | Editorial Commentary: Fosfomycin: The Current Status of the Drug. Clin Infect Dis. 2015, vol. 61(7) p. 1144-6. doi: 10.1093/cid/civ443 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16056 | DOI: | 10.1093/cid/civ436 | ORCID: | Journal: | Clinical Infectious Diseases | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/26063723 | Type: | Journal Article | Subjects: | Fosfomycin Microbial drug resistance Pharmacology Prostatitis |
Type of Clinical Study or Trial: | Case Series and Case Reports |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.